Published on 9 May 2022 on Simply Wall St. via Yahoo Finance
Some stocks are best avoided. We don't wish catastrophic capital loss on anyone. Spare a thought for those who held Enzo Biochem, Inc. (NYSE:ENZ) for five whole years - as the share price tanked 73%. Shareholders have had an even rougher run lately, with the share price down 27% in the last 90 days.
It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that.
See our latest analysis for Enzo Biochem